SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-017898
Filing Date
2020-09-16
Accepted
2020-09-16 16:19:54
Documents
51
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 490473
2 ex31-1.htm EX-31.1 12886
3 ex32-1.htm EX-32.1 7566
  Complete submission text file 0001493152-20-017898.txt   2548554

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lung-20200630.xml EX-101.INS 327643
5 XBRL SCHEMA FILE lung-20200630.xsd EX-101.SCH 42884
6 XBRL CALCULATION FILE lung-20200630_cal.xml EX-101.CAL 39906
7 XBRL DEFINITION FILE lung-20200630_def.xml EX-101.DEF 123662
8 XBRL LABEL FILE lung-20200630_lab.xml EX-101.LAB 275884
9 XBRL PRESENTATION FILE lung-20200630_pre.xml EX-101.PRE 197033
Mailing Address 350 W. 800 N. SUITE 214 SALT LAKE CITY UT 84103
Business Address 350 W. 800 N. SUITE 214 SALT LAKE CITY UT 84103 (801) 736-0729
PROLUNG INC (Filer) CIK: 0001541884 (see all company filings)

IRS No.: 201922768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38362 | Film No.: 201179071
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences